Jump to navigation
NDRI researchers will be collaborating with others to quantify the social and economic costs of cannabis and opioid use in Australia.
The NT PHN have commissioned NCETA to conduct a series of workshops as part of the PHN’s continuing professional development (CPD) Pop-Up Events in
There are currently no empirically validated treatment options for adolescents with PTSD and SUD.
The Climate and Preventure (CAP) long-term follow up is an opportunistic extension of the landmark CAP study, whereby fo
Behavioural and pharmacological approaches to smoking cessation are effective at helping people to quit but long-term quit rates remain low, especi
This project aims to improve access for Aboriginal and Torres Strait Islander people to culturally appropriate, evidence‐based information about ice.
NDRI will lead a multi-site NHMRC-funded world-first trial of a promising new medication for dependence on ice.
This project aims to investigate impediments to uptake of ‘take-home’ naloxone in Australia.
This project will investigate the social practices associated with men’s use of performance and image enhancing drugs
This project will review the evidence for the medicinal use of cannabis and cannabinoid products for a number of key medical conditions.
Substance use among pregnant women is a significant public health issue.
The national centres are supported by funding from the Australian Government under the Drug and Alcohol Program
Page last updated: Thursday 11 October 2018